Why did Ingersoll Rand (IR) stock move recently?

On 9/1/2026, Ingersoll Rand moved -3.1% — IR fell 3.13% with the broader market amid a risk-off session driven by geopolitical tensions, rising bond yields, and tariff concerns, with no company-specific catalyst reported on Sept 1. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Ingersoll Rand (IR) overvalued or fairly valued?

MarketChacha shows Ingersoll Rand's valuation in context — a trailing P/E of about 51.9, a forward P/E of about 19.5, a price-to-book of about 2.9 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Ingersoll Rand's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.88×) from reported figures — education, not a rating.

What is Ingersoll Rand's revenue?

Ingersoll Rand reported revenue of $7.7B for FY2025, with net profit of $581.4M, per official filings.

What is the share price of Ingersoll Rand (IR)?

Ingersoll Rand last traded at $76.36 (+1.3% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Ingersoll Rand

IR · NYSE · Industrials · United States

Snapshot

TickerIR

ExchangeNYSE

SectorIndustrials

IndustrySpecialty Industrial Machinery

CountryUnited States

Employees21,000

HeadquartersDavidson, United States

Websitewww.irco.com

Filings tracked12

About Ingersoll Rand

Ingersoll Rand Inc. provides mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services a range of air and gas compression and treatment equipment, vacuum and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment; and other specialized equipment, including aftermarket parts, consumables and services, air treatment equipment, controls, other accessories, and services under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, and other brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for precision dosing, liquid and solid transfer, dispensing, gas compression and sampling, pressure management, flow control, powder handling, and other applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brands. This segment's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. It sells its products through a network of direct sales representatives and independent distributors. It has a strategic alliance with Garrett Motion. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.

Who owns it

Insiders0.2%
Institutions99.8%
Public & other0.0%

1,275 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.7.81%
Capital World Investors7.20%
Price (T.Rowe) Associates Inc6.97%
Capital Research Global Investors6.50%
Vanguard Capital Management LLC6.31%
Vanguard Portfolio Management LLC4.34%
T. Rowe Price Investment Management, Inc.4.14%
State Street Corporation4.10%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Margin has compressed by about 3.7 points over the period — profitability is trending down.

Cash conversion1.88×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend11.3% → 7.6%

Margin has compressed by about 3.7 points over the period — profitability is trending down.

Return on equity5.8%

Latest ROE of 5.8% is on the low side — the business earns a modest return on shareholder capital.

Growth qualityrev 5% · PAT -14%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $2.2B · EPS 1.02

Est. earnings growth +6.5%

Next fiscal year

Rev $8.5B · EPS 3.92

Est. earnings growth +10.2%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$7.7B

Net margin

7.6%

ROE

5.8%

Revenue CAGR (2y)

+5.5%

Profit CAGR (2y)

-13.6%

EPS (FY2025)

1.45

Net profit (FY2025)

$581.4M

Ask MarketChacha about IR

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Sep 1, 2026
IR fell 3.13% with the broader market amid a risk-off session driven by geopolitical tensions, rising bond yields, and tariff concerns, with no company-specific catalyst reported on Sept 1.
source 1 ↗source 2 ↗· confidence: low
Jul 22, 2026
No clear company-specific catalyst; shares rose alongside broader industrial sector strength on continued positive sentiment around recent order growth and backlog trends.
· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$7.7B	$581.4M	1.45	7.6%	5.8%
FY2024	$7.2B	$838.6M	2.06	11.6%	8.2%
FY2023	$6.9B	$778.7M	1.90	11.3%	8.0%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$2.0B	$256.8M	0.66	12.5%
2026Q1	$1.8B	$192.1M	0.49	10.4%
2025Q3	$2.0B	$244.1M	0.61	12.5%
2025Q2	$1.9B	$-115.3M	-0.29	-6.1%
2025Q1	$1.7B	$186.5M	0.46	10.9%
2024Q3	$1.9B	$221.6M	0.54	11.9%
2024Q2	$1.8B	$185.0M	0.45	10.2%
2024Q1	$1.7B	$202.2M	0.50	12.1%
2023Q3	$1.7B	$208.3M	0.51	12.0%
2023Q2	$1.7B	$179.5M	0.44	10.6%
2023Q1	$1.6B	$161.1M	0.39	9.9%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC7/31/2026
8-K — Results of operations, Exhibits
SEC7/30/2026material
8-K — Executive/director change, Shareholder vote results, Exhibits
SEC6/16/2026material
10-Q filing
SEC4/29/2026
8-K — Results of operations, Exhibits
SEC4/28/2026material
10-K filing
SEC2/17/2026
8-K — Results of operations, Exhibits
SEC2/12/2026material

2025

8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC12/17/2025material
10-Q filing
SEC10/31/2025
8-K — Results of operations, Exhibits
SEC10/30/2025material
8-K — Results of operations, Exhibits
SEC7/31/2025material
10-Q filing
SEC7/31/2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.